Description
IGF::OT::IGF ANTI-CARDIOLIPIN IGG/IGM ELISA KITS AND SERVICES.
First action · last action
2013-10-09 · 2013-10-09
Transactions
1
First transaction's obligation
$0
Base + all options value (sum of deltas)
$16,328
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
SMALL BUSINESS SET ASIDE - TOTAL
Offers received
3
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-10-09+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-10-09 | +$0 | $0 | IGF::OT::IGF ANTI-CARDIOLIPIN IGG/IGM ELISA KITS AND SERVICES. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI LL3JF6BUDL58)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25918N2695 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $7,100 | FY2018 |
| VA25917J4606 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $17,040 | FY2017 |
| VA25916J0001 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $13,103 | FY2016 |
| VA25915J5974 | 259-NETWORK CONTRACT OFFICE 19 · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $12,785 | FY2015 |
| VA25914A0174 | 259-NETWORK CONTRACT OFFICE 19 · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2014 |
| VA25914J4173 | 259-NETWORK CONTRACT OFFICE 19 · Q301 · MEDICAL- LABORATORY TESTING | $16,102 | FY2014 |
Other recipients under Q301 from 259-NETWORK CONTRACT OFFICE 19 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25916J1872 | ARUP LABORATORIES INC | 259-NETWORK CONTRACT OFFICE 19 | $950,000 | FY2016 |
| VA25916J1873 | ARUP LABORATORIES INC | 259-NETWORK CONTRACT OFFICE 19 | $15,700 | FY2016 |
| VA25916J1869 | ARUP LABORATORIES INC | 259-NETWORK CONTRACT OFFICE 19 | $29,870 | FY2016 |
| VA25916J1870 | ARUP LABORATORIES INC | 259-NETWORK CONTRACT OFFICE 19 | $0 | FY2016 |
| VA25916J1078 | LABORATORY CORPORATION OF AMERICA | 259-NETWORK CONTRACT OFFICE 19 | $486,000 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA25914D0347_3600 · retrieved 2026-09-26.